Established in year 2014, YidoBio is named after King Sejong who is known for the greatest.
achievements in Korea’s history, despite being a severe diabetic. His given name was Yido.
YidoBio aims to be the first one-stop diabetes specialty company in Korea.
While we develop cell therapy for the treatment of diabetes, we also manufacture and distribute diabetic supplies.
We have a strong sales network in the Korean diabetic medical devices market.
YidoBio is funded by venture capital firms and i-SENS.
Alex Leesong PhD JD (Seoul National University, Purdue University, University of Sydney Law School, i-SENS)
Margaret Leesong PhD JD (Seoul National University, Purdue University, University of Sydney Law School, i-SENS)
Hye Yeon Hwang PhD (Seoul National University, University of California at Berkeley)
Eun Ja Kim PhD (Seoul National University, Scripps Research Institute, LG)
Jason Shim PhD (Ajou University, Samsung Seoul Hospital)
Kate Yoon MS (Seoul National University, LG, Bayer Korea)
SJ Yoon (BD Korea, Salesman of the Year Award in BD Asia Pacific, 25 years experience in sales of diabetic medical devices in Korea)
Registered Offices: 5th Floor, i-SENS Bldg, 43 BanPo-daero 28-gil, SeoCho-gu, Seoul, South Korea
R&D Center: Suite 2010, Smart Bay, 123 BeolMal-ro, DongAn-gu, AnYang-si, KyungGi-do, 14056 , South Korea
Factory: 24-13 DongOh-4-gil, HyangNam-eup, HwaSung-si, KyungGi-do, 14056 , South Korea
Skype ID: mleesong